发明名称 Farmasoytisk sammensetning omfattende polypetid/nukleinsyre for behandling av retinale degenererende sykdommer, vektor, isolert polypeptid, renset antistoff og anvendelse av polypeptid, nukleinsyre og antistoff, samt fremgangsmater og kit
摘要 Disclosed are methods and compositions for early diagnosis, monitoring and treatment of retinal dystrophy, age-related macular degeneration, Bardet-Biedel syndrome, Bassen-kornzweig syndrome, best disease, choroidema, gyrate atrophy, congenital amourosis, refsun syndrome, stargardt disease and Usher syndrome. In particular, the invention relates to a protein, termed "Rdcvf1," that is differentially transcribed and expressed in subjects suffering from retinal dystrophies and the like, such as retinal dystrophy and age-related macular degeneration compared with nonsufferers, antibodies which recognize this protein, and methods for diagnosing such conditions.
申请公布号 NO331277(B1) 申请公布日期 2011.11.14
申请号 NO20030004452 申请日期 2003.10.03
申请人 NOVARTIS AG 发明人 LEVEILLARD THIERRY;MOHAND-SAID SADDEK;SAHEL JOSE ALAIN;HICKS DAVID
分类号 C07K14/47;G01N33/53;A61K35/76;A61K38/00;A61K38/17;A61K48/00;A61P27/02;C07K16/18;C12N5/10;C12N15/09;C12N15/12;C12P21/02;C12P21/08;C12Q1/68;C12R1/91;G01N33/566;G01N33/577 主分类号 C07K14/47
代理机构 代理人
主权项
地址